176 related articles for article (PubMed ID: 14751286)
41. Cognitive-behavioral phenotypes of Williams syndrome are associated with genetic variation in the GTF2I gene, in a healthy population.
Crespi BJ; Hurd PL
BMC Neurosci; 2014 Nov; 15():127. PubMed ID: 25429715
[TBL] [Abstract][Full Text] [Related]
42. [Williams syndrome].
Alleva E; Cirulli F; Calamandrei G; Rondinini C; Capirci O; Aloe L; Volterra V
Ann Ist Super Sanita; 1999; 35(2):211-9. PubMed ID: 10645654
[TBL] [Abstract][Full Text] [Related]
43. Characterization and expression pattern of the frizzled gene Fzd9, the mouse homolog of FZD9 which is deleted in Williams-Beuren syndrome.
Wang YK; Spörle R; Paperna T; Schughart K; Francke U
Genomics; 1999 Apr; 57(2):235-48. PubMed ID: 10198163
[TBL] [Abstract][Full Text] [Related]
44. Transcription Factor 2I Regulates Neuronal Development via TRPC3 in 7q11.23 Disorder Models.
Deurloo MHS; Turlova E; Chen WL; Lin YW; Tam E; Tassew NG; Wu M; Huang YC; Crawley JN; Monnier PP; Groffen AJA; Sun HS; Osborne LR; Feng ZP
Mol Neurobiol; 2019 May; 56(5):3313-3325. PubMed ID: 30120731
[TBL] [Abstract][Full Text] [Related]
45. Duplication of GTF2I results in separation anxiety in mice and humans.
Mervis CB; Dida J; Lam E; Crawford-Zelli NA; Young EJ; Henderson DR; Onay T; Morris CA; Woodruff-Borden J; Yeomans J; Osborne LR
Am J Hum Genet; 2012 Jun; 90(6):1064-70. PubMed ID: 22578324
[TBL] [Abstract][Full Text] [Related]
46. TFII-I and AP2α Co-Occupy the Promoters of Key Regulatory Genes Associated with Craniofacial Development.
Miranda P; Enkhmandakh B; Bayarsaihan D
Cleft Palate Craniofac J; 2018 Jul; 55(6):865-870. PubMed ID: 28085512
[TBL] [Abstract][Full Text] [Related]
47. In-depth analysis of spatial cognition in Williams syndrome: A critical assessment of the role of the LIMK1 gene.
Gray V; Karmiloff-Smith A; Funnell E; Tassabehji M
Neuropsychologia; 2006; 44(5):679-85. PubMed ID: 16216290
[TBL] [Abstract][Full Text] [Related]
48. Presenting phenotype and clinical evaluation in a cohort of 22 Williams-Beuren syndrome patients.
Ferrero GB; Biamino E; Sorasio L; Banaudi E; Peruzzi L; Forzano S; di Cantogno LV; Silengo MC
Eur J Med Genet; 2007; 50(5):327-37. PubMed ID: 17625998
[TBL] [Abstract][Full Text] [Related]
49. Integrative network analysis reveals biological pathways associated with Williams syndrome.
Kimura R; Swarup V; Tomiwa K; Gandal MJ; Parikshak NN; Funabiki Y; Nakata M; Awaya T; Kato T; Iida K; Okazaki S; Matsushima K; Kato T; Murai T; Heike T; Geschwind DH; Hagiwara M
J Child Psychol Psychiatry; 2019 May; 60(5):585-598. PubMed ID: 30362171
[TBL] [Abstract][Full Text] [Related]
50. Generation of a mouse model for a conditional inactivation of Gtf2i allele.
Enkhmandakh B; Stoddard C; Mack K; He W; Kaback D; Yee SP; Bayarsaihan D
Genesis; 2016 Jul; 54(7):407-12. PubMed ID: 27194223
[TBL] [Abstract][Full Text] [Related]
51. Williams-Beuren syndrome hypercalcemia: is TRPC3 a novel mediator in calcium homeostasis?
Letavernier E; Rodenas A; Guerrot D; Haymann JP
Pediatrics; 2012 Jun; 129(6):e1626-30. PubMed ID: 22566418
[TBL] [Abstract][Full Text] [Related]
52. Williams syndrome and the elastin gene in Thai patients.
Ruangdaraganon N; Tocharoentanaphol C; Kotchabhakdi N; Khowsathit P
J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S174-8. PubMed ID: 10730539
[TBL] [Abstract][Full Text] [Related]
53. Intracisternal Gtf2i Gene Therapy Ameliorates Deficits in Cognition and Synaptic Plasticity of a Mouse Model of Williams-Beuren Syndrome.
Borralleras C; Sahun I; Pérez-Jurado LA; Campuzano V
Mol Ther; 2015 Nov; 23(11):1691-1699. PubMed ID: 26216516
[TBL] [Abstract][Full Text] [Related]
54. Expression of the transcription factor, TFII-I, during post-implantation mouse embryonic development.
Fijalkowska I; Sharma D; Bult CJ; Danoff SK
BMC Res Notes; 2010 Jul; 3():203. PubMed ID: 20642858
[TBL] [Abstract][Full Text] [Related]
55. Parieto-occipital grey matter abnormalities in children with Williams syndrome.
Boddaert N; Mochel F; Meresse I; Seidenwurm D; Cachia A; Brunelle F; Lyonnet S; Zilbovicius M
Neuroimage; 2006 Apr; 30(3):721-5. PubMed ID: 16380272
[TBL] [Abstract][Full Text] [Related]
56. Contribution of CYLN2 and GTF2IRD1 to neurological and cognitive symptoms in Williams Syndrome.
van Hagen JM; van der Geest JN; van der Giessen RS; Lagers-van Haselen GC; Eussen HJ; Gille JJ; Govaerts LC; Wouters CH; de Coo IF; Hoogenraad CC; Koekkoek SK; Frens MA; van Camp N; van der Linden A; Jansweijer MC; Thorgeirsson SS; De Zeeuw CI
Neurobiol Dis; 2007 Apr; 26(1):112-24. PubMed ID: 17270452
[TBL] [Abstract][Full Text] [Related]
57. WBSCR14, a putative transcription factor gene deleted in Williams-Beuren syndrome: complete characterisation of the human gene and the mouse ortholog.
de Luis O; Valero MC; Jurado LA
Eur J Hum Genet; 2000 Mar; 8(3):215-22. PubMed ID: 10780788
[TBL] [Abstract][Full Text] [Related]
58. Growth defects and impaired cognitive-behavioral abilities in mice with knockout for Eif4h, a gene located in the mouse homolog of the Williams-Beuren syndrome critical region.
Capossela S; Muzio L; Bertolo A; Bianchi V; Dati G; Chaabane L; Godi C; Politi LS; Biffo S; D'Adamo P; Mallamaci A; Pannese M
Am J Pathol; 2012 Mar; 180(3):1121-1135. PubMed ID: 22234171
[TBL] [Abstract][Full Text] [Related]
59. [Atypical deletions in Williams-Beuren syndrome].
Ramírez-Velazco A; Domínguez-Quezada MG
Rev Med Inst Mex Seguro Soc; 2017; 55(5):615-620. PubMed ID: 29193944
[TBL] [Abstract][Full Text] [Related]
60. Neuronal Gtf2i deletion alters mitochondrial and autophagic properties.
Nir Sade A; Levy G; Schokoroy Trangle S; Elad Sfadia G; Bar E; Ophir O; Fischer I; Rokach M; Atzmon A; Parnas H; Rosenberg T; Marco A; Elroy Stein O; Barak B
Commun Biol; 2023 Dec; 6(1):1269. PubMed ID: 38097729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
